Ecology and evolution of dormant metastasis

Area of Science:

• Oncology
• Cancer Metastasis Research
• Cellular Biology

Background:

• Sequential dissemination from primary tumors, often bone metastasis, is a key driver of cancer progression in early-stage disease.
• Disseminated tumor cells (DTCs) can remain dormant for extended periods, evading current treatments for asymptomatic residual disease.
• Dormant DTCs pose a significant clinical challenge due to their potential for relapse, adaptation, and therapy resistance.

Purpose of the Study:

• To review current understanding of dormant metastasis cell mechanisms.
• To explore factors influencing DTC survival, microenvironment interactions, and colonization.
• To discuss the process of metastasis arising from metastasis.

Main Methods:

• Review of genetic studies and clinical data on cancer metastasis.
• Analysis of mechanisms underlying disseminated tumor cell dormancy and reactivation.
• Discussion of cell-cell and cell-microenvironment communication in metastatic progression.

Main Results:

• Dormant DTCs can persist for years, posing a risk of late relapse.
• Primary metastatic lesions can actively seed secondary metastases in other organs.
• Adaptation and therapy resistance can develop in reactivated DTCs.

Conclusions:

• Understanding DTC dormancy is crucial for developing effective adjuvant therapies.
• Metastasis can be a multi-step process, including metastasis seeding secondary metastases.
• Further research into DTC survival and reactivation mechanisms is needed to combat metastatic cancer.